How Surfactants Are Studied as Oral Mucosal Permeation Enhancers

Surfactants are studied as oral mucosal permeation enhancers by measuring whether their amphiphilic interaction with epithelial membranes increases transport of peptides or hydrophilic markers without causing unacceptable barrier disruption. Researchers compare surfactant type, charge, concentration, exposure time, peptide flux, epithelial resistance, tissue morphology, and recovery after exposure. Anionic, cationic, and nonionic surfactants can behave differently, and a large increase in permeability may reflect either controlled barrier modification or tissue injury unless those possibilities are tested separately.

Surfactants form one of the classic chemical-enhancer groups within Permeation Enhancers for Peptide Oral Films. Their dual affinity for water and less-polar molecular environments makes them useful for formulation, but it also allows them to interact with biological membranes and proteins.

Research-use notice: This article focuses on surfactants as experimental oral mucosal permeation enhancers, including cationic, anionic, and nonionic surfactants, concentration-dependent peptide transport, membrane interaction, and epithelial safety testing. InStrips products are intended only for research and analytical use and are not intended to diagnose, treat, cure, or prevent peptide absorption disorders, oral mucosal conditions, tissue injury, or any other medical condition.

Why Amphiphilic Molecules Can Affect an Epithelial Barrier

A surfactant contains:

• a hydrophilic region
• a hydrophobic region

This allows the same molecule to associate with both aqueous environments and lipid- or protein-rich biological structures.

In an oral mucosal experiment, those interactions can change the way a peptide partitions into or crosses the epithelium.

Surfactants Are Commonly Divided by Charge

Major categories include:

• anionic surfactants
• cationic surfactants
• nonionic surfactants

The charge state can influence both formulation behaviour and interaction with negatively charged biological surfaces.

Sodium Lauryl Sulfate Is an Anionic Example

Sodium lauryl sulfate, also called sodium dodecyl sulfate in many laboratory contexts, is a strongly amphiphilic anionic surfactant.

It can interact extensively with:

• proteins
• membranes
• lipid structures

which is why permeability increases produced by SLS need especially careful tissue-integrity interpretation.

Cetrimide Provides a Cationic Example

Cetrimide contains a positively charged surfactant headgroup.

It has been investigated directly in peptide buccal-permeation research.

Electrostatic interaction with mucosal and epithelial components may contribute to behaviour that differs from anionic surfactants.

Nonionic Surfactants Generally Lack a Formal Charge

Examples across pharmaceutical formulation include members of families such as:

• polysorbates
• Brij-type surfactants
• poloxamers

The absence of formal charge does not mean absence of membrane interaction.

Researchers First Ask Whether the Surfactant Changes Permeability

A simple experimental comparison can include:

• peptide without surfactant
• peptide plus surfactant

under otherwise matched conditions.

Peptide appearance in the receiver compartment can then be measured over time.

Apparent Permeability Provides One Quantitative Endpoint

The apparent permeability coefficient can be calculated from the rate at which peptide crosses the tissue.

This makes it possible to compare:

• untreated barrier
• different surfactants
• different concentrations

The Enhancement Ratio Should Be Read Together With Baseline Permeability

If a peptide has extremely low baseline transport, even a relatively modest absolute increase can produce a large enhancement ratio.

This is why both relative and absolute transport values matter.

PACAP Has Been Used as a Direct Peptide Model

One particularly useful buccal experiment evaluated pituitary adenylate cyclase-activating polypeptide, or PACAP, across freshly excised porcine buccal mucosa.

The study directly compared several enhancer strategies rather than relying only on small hydrophilic marker molecules.

Cetrimide Produced a Large Increase in PACAP Permeability

Under that experimental protocol, 5% cetrimide produced a substantially greater apparent permeability than buffer alone.

This establishes that the cationic surfactant was capable of altering peptide transport across the porcine buccal barrier under the tested conditions.

The Size of the Increase Does Not Answer the Safety Question

Strong surfactant activity can arise because epithelial structures are being altered.

Researchers therefore need to ask:

• Was the barrier reversibly modified?
• Were cells damaged?
• Was tissue structure preserved?

Concentration Dependence Is Especially Important for Surfactants

Below a certain exposure level, a surfactant may have little effect.

As concentration increases, researchers may observe:

• greater permeability
• greater membrane perturbation
• greater irritation potential

These do not necessarily increase at the same rate.

Micelles Add Another Concentration-Dependent Behaviour

Above the critical micelle concentration, surfactant molecules increasingly assemble into micellar structures.

This can change:

• free surfactant concentration
• peptide solubilization
• membrane interaction

and make simple concentration-response predictions unreliable.

Surfactants Can Interact With the Peptide Itself

A surfactant may alter:

• peptide aggregation
• solubility
• surface adsorption
• conformation

before either component reaches the epithelium.

A Permeability Increase Can Therefore Have More Than One Cause

Measured enhancement could reflect a combination of:

• greater peptide availability
• changed tissue partitioning
• membrane perturbation
• intercellular barrier effects

Oral Mucosa Should Not Be Treated Like Skin

Although many chemical penetration enhancers were initially studied in skin, the buccal epithelium has a different barrier structure and lipid organization.

A surfactant that performs strongly in transdermal delivery may therefore behave differently in oral tissue.

Buccal Enhancement May Involve Protein Domains as Well as Lipids

Mechanistic work suggests that buccal enhancers can influence:

• drug partitioning into tissue
• intercellular lipids
• epithelial protein domains
• surface retention

rather than acting through one universal lipid-disruption mechanism.

Electrical Measurements Help Track Barrier Perturbation

Researchers can monitor:

• transepithelial electrical resistance
• electrical conductance

before, during, and after surfactant exposure.

A substantial reduction in resistance can indicate increased ionic barrier permeability.

Electrical Change Is Not Equivalent to Peptide Flux

Ions are far smaller than peptides.

A large electrical-barrier change may produce a smaller or more complex effect on macromolecular transport.

Hydrophilic Markers Provide Another Barrier Probe

Researchers may include compounds such as:

• mannitol
• fluorescent dextran

to determine whether the surfactant increases transport through hydrophilic pathways.

Direct Peptide Measurement Is Still Needed

A surfactant can strongly increase marker permeability while producing a different response for a peptide because of differences in:

• size
• charge
• conformation
• tissue binding

Histology Can Reveal Overt Structural Damage

After exposure, oral tissue can be fixed, sectioned, and examined microscopically for changes such as:

• surface-layer loss
• cell separation
• epithelial disruption

Older In Vivo Work Shows Why This Matters

Classic rat oral-mucosa experiments found concentration-dependent permeability increases after exposure to several surfactants.

More potent ionic surfactants also produced structural changes in the mucosa, illustrating that permeability enhancement and tissue alteration can occur together.

SLS Has Demonstrated This Problem in Human Oral Tissue

Experimental human oral mucosa exposed to SLS showed increased permeability to water together with marked surface epithelial disruption under the protocol tested.

This provides a useful warning against treating every surfactant-induced permeability increase as a desirable formulation effect.

Formulation Context Can Modify the Surfactant Effect

The same SLS study found that combining SLS with other components changed the barrier response.

This demonstrates that surfactant behaviour can depend on:

• co-formulated compounds
• concentration
• vehicle composition

Film Incorporation Changes the Exposure Pattern Again

In a peptide oral film, surfactant is not usually presented as a simple bulk solution.

It must first be released from the hydrated matrix.

Local exposure can therefore depend on:

• polymer type
• film hydration
• surfactant loading
• film residence time

Slow Release Could Reduce the Peak Surfactant Concentration

A film might expose tissue to a lower concentration for a longer period compared with a solution bolus.

Whether this improves the permeability-tolerability balance needs direct testing.

Surfactants Can Alter the Film Before Altering the Tissue

Adding an amphiphilic compound can change:

• polymer interactions
• mechanical strength
• hydration
• peptide release

so the complete film should be characterized after surfactant incorporation.

Reversibility Can Be Tested After Surfactant Removal

If barrier resistance or marker permeability returns toward baseline, this supports evidence of temporary rather than persistent alteration under the experimental conditions.

Reversibility does not itself establish long-term human tolerability.

Research Note: A Cationic Surfactant Has Been Tested With an Intact Peptide Across Buccal Tissue

A primary study measured PACAP permeability across freshly excised porcine buccal mucosa and reported a 46.5-fold enhancement ratio in the presence of 5% cetrimide under the experimental conditions. The researchers also compared sodium deoxycholate and thiolated chitosan-based systems.

The result demonstrates direct surfactant-associated enhancement of peptide transport in an ex vivo buccal model. It does not establish that the same concentration would be suitable for repeated human mucosal exposure or for a different peptide-film formulation.

Fatty Acids Provide a Different Structure-Activity Problem

Unlike grouping surfactants mainly by ionic character, fatty-acid enhancer research can systematically vary carbon-chain length and unsaturation.

That structure-performance relationship is examined in How Fatty Acids and Related Lipid-Based Enhancers Are Studied.

How to Read a Surfactant Enhancement Result

A convincing surfactant study should specify the surfactant type, ionic class, concentration, exposure duration, peptide or marker, tissue model, flux or Papp, barrier measurement, tissue assessment, and recovery data.

The largest enhancement ratio should not automatically be treated as the best formulation. With membrane-active surfactants, the scientifically useful question is whether permeability can be increased within a concentration range that preserves an interpretable and sufficiently intact mucosal barrier.